Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2012
06/20/2012CN101204502B Application of anti-atherosclerosis Chinese traditional medicine and fistular onion stalk extractive on curing atherosclerosis
06/20/2012CN101098709B Use of a trpc channel for the treatment of a cardiovascular disease
06/19/2012USRE43481 Diazepan derivatives or salts thereof
06/19/2012US8202856 Triazole oxadiazoles derivatives
06/19/2012US8202845 Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012CA2349202C Method of preparing stable suspensions of insoluble microparticles
06/14/2012WO2012078859A2 Protein kinase d inhibitors
06/14/2012WO2012078746A2 Compositions and methods for mobilizing stem cells
06/14/2012WO2012078587A1 Cardio-protective agents from kiwifruits
06/14/2012WO2012078070A1 Fungicide
06/14/2012WO2012077968A2 Complex formulation comprising lercanidipine hydrochloride and valsartan and method for the preparation thereof
06/14/2012WO2012077108A1 Multifunctional nitroxide derivatives and uses thereof
06/14/2012WO2012077051A1 Hydroxylated aminotriazole derivatives as alx receptor agonists
06/14/2012WO2012076988A1 A complex of garcinol, cyclodextrin and method thereof
06/14/2012WO2012076667A1 Compounds for treatment of heart failure
06/14/2012WO2012076443A1 Liposomal formulation of dalcetrapib
06/14/2012WO2012075917A1 Compounds
06/14/2012WO2012075678A1 Substituted thiazolyl pyrazolo pyridine compound and medicinal use thereof
06/14/2012WO2012075570A1 Bioactive peptides and proteins containing bioactive peptides, their uses and processes for making the same
06/14/2012WO2012056478A8 Oxazoline and isoxazoline derivatives as crac modulators
06/14/2012WO2012040511A3 Compounds that modulate intracellular calcium
06/14/2012WO2011163531A3 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases
06/14/2012US20120149778 Compounds
06/14/2012US20120149777 Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
06/14/2012US20120149765 Sgk1 as diagnostic and therapeutic target
06/14/2012US20120149758 Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization
06/14/2012US20120149748 Pharmaceutical Cream Compositions and Methods of Use
06/14/2012US20120149742 Heterocyclic derivatives as modulators of ion channels
06/14/2012US20120149733 Piperidinyl compound as a modulator of chemokine receptor activity
06/14/2012US20120149732 Multifunctional linkers and methods for the use thereof
06/14/2012US20120149729 Metalloenzyme inhibitor compounds
06/14/2012US20120149721 Methylpyrrolopyrimidinecarboxamides
06/14/2012US20120149703 Aza-substituted spiro derivatives
06/14/2012US20120149702 Inhibitors of cellular necrosis
06/14/2012US20120149701 Certain chemical entities, compositions and methods
06/14/2012US20120149700 2-cyanophenyl fused heterocyclic compounds, and compostions and uses thereof
06/14/2012US20120149696 Ethylene diamine modulators of fatty acid hydrolase
06/14/2012US20120149694 Substituted piperidines
06/14/2012US20120149693 Therapeutic compounds
06/14/2012US20120149688 Platelet adp receptor inhibitors
06/14/2012US20120149682 Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
06/14/2012US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
06/14/2012US20120149674 Diaryl Substituted Alkanes
06/14/2012US20120149651 Caveolin peptides and their use as therapeutics
06/14/2012US20120148692 Novel herbal formulation for the prevention and management of type-2 diabetes mellitus and vascular complications associated with diabetes
06/14/2012US20120148691 Compositions and methods for the prevention and treatment of hypertension
06/14/2012US20120148685 Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
06/14/2012US20120148664 Chemical modifications motifs for mirna inhibitors and mimetics
06/14/2012US20120148657 Lipoxygenase and Its Use in Wound Healing
06/14/2012US20120148642 Multi-domain amphipathic helical peptides and methods of their use
06/14/2012US20120148640 Pharmaceutical Composition Comprising Pimobendan
06/14/2012US20120148637 Nanoparticulate olmesartan medoxomil compositions, process for the preparation thereof and pharmaceutical compositions containing them
06/14/2012US20120148630 Prevention of infarct expansion
06/14/2012US20120148605 Immunomodulatory Methods And Systems For Treatment And/Or Prevention Of Atherosclerosis And Related Proteins, Peptide And Compositions
06/14/2012US20120148593 Neutralizing Antibodies And Methods Of Use Thereof
06/14/2012US20120148581 Use of nkg2d inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes
06/14/2012US20120148572 Novel antibodies
06/14/2012US20120148565 Increasing lifespan by modulation of wwp-1 and ubc-18
06/14/2012US20120148560 Neuroprotection from brain anoxia and reperfusion injury during stroke and compositions of pkg pathway activators and method of use thereof
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148547 Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders
06/14/2012US20120148546 Pericyte progenitor cells and methods of generating and using same
06/14/2012US20120148545 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
06/14/2012US20120148540 Proliferated cell lines and uses thereof
06/14/2012US20120148504 Complex of garcinol, cyclodextrin and method thereof
06/14/2012US20120148493 Composite Materials Loaded with Therapeutic and Diagnostic Agents Comprising Polymer Nanoparticles and Polymer Fibers
06/14/2012US20120148489 Targeting Kidney Mesangium With Nanoparticles of Defined Diameter
06/14/2012DE102010062544A1 New substituted 1-benzylcycloalkylcarboxylic acid compounds are soluble guanylate cyclase activators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertension, pulmonary hypertension and vascular disease
06/14/2012CA2820984A1 A complex of garcinol, cyclodextrin and method thereof
06/14/2012CA2820763A1 Multifunctional nitroxide derivatives and uses thereof
06/14/2012CA2820229A1 Cardio-protective agents from kiwifruits
06/14/2012CA2820065A1 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
06/14/2012CA2819130A1 Compositions and methods for mobilizing stem cells
06/14/2012CA2818018A1 Liposomal formulation of dalcetrapib
06/13/2012EP2463290A1 Thienooxazepine derivative
06/13/2012EP2462933A1 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
06/13/2012EP2462137A1 Crystalline salts of methyl 2- ( (r) - ( 3-chloro phenyl) ( (r) -l- ( (s) -2- (methylamino) -3- ( (r) -tetrahydro-2h-pyran-3-yl) propylcarbamoyl )
06/13/2012EP2462121A1 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
06/13/2012EP1836180B1 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
06/13/2012EP1781635B1 Potassium channel inhibitors
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1447095B1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012CN1980910B Benzopyran compound for treating arrhythmia
06/13/2012CN1688337B Use of digoxin immune FAB (ovine) for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients
06/13/2012CN102498099A HSL inhibitors useful in the treatment of diabetes
06/13/2012CN102498091A Glycine compound
06/13/2012CN102497872A Inhibitor of inflammatory conditions
06/13/2012CN102497857A Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
06/13/2012CN102492666A Enzyme preparation, application and method for extracting pueraria flavonid by enzyme preparation thereof
06/13/2012CN102492654A Kit for separating human umbilical cord blood stem cells and its using method
06/13/2012CN102492626A Nannochloropsis sp and application thereof
06/13/2012CN102492594A Bamboo juice wine and preparation method thereof
06/13/2012CN102492019A Silkworm protein source dipeptide TE and its purpose
06/13/2012CN102492014A Preparation method of tanshinone IIA tocopheryl acid phenolic ester derivative
06/13/2012CN102492008A Active extract containing isocarthamidin 7-O-beta-D-glucuronidase and use thereof
06/13/2012CN102491979A 1-hydroxyethyl-5-substituted indolone derivative and preparation method and application thereof
06/13/2012CN102491971A Chiral ((4-methyl-2-propyl-1H-benzimidazole-6-amide)-1-radical) methyl diphenyl compound, as well as preparation method and application thereof
1 ... 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 ... 1595